07:30 - 08:30		Morning Session
Meeting Room 309
	07:30 - 07:45	Shorter duration and lower dose of peginterferon alfa-2a therapy results in inferior HBeAg seroconversion rates compared with the duration and dose of 48 weeks and 180 µg:NEPTUNE Study
		Hui Wang, Shanghai
	07:45 - 08:00	The importance of  HBsAg quantification and sustained Immune Control in CHB
		Jie Xu, Shanghai
	08:00 - 08:15	The Individualized RGT treatment Strategy for HCV
		Guofeng Chen, Beijing
	08:15 - 08:30	The updated research highlight of HCV treatment
		Yanyan Yu, Beijing
08:30 - 09:00		State-of-the Art Lecture 3
Meeting Room 309
SOTA 3	08:30 - 09:00	NDM-1 as a unique marker of antibiotic resistance: when two worlds collide
		Timothy Walsh, Brisbane
09:15 - 10:45		Concurrent Session 7
Meeting Room 310		HBV Infection - Science for Clinicians
CS 7.1	09:15 - 09:35	Host-immune response: Influence on antiviral efficacy in HBV-infected individuals
		Fusheng Wang, Beijing
CS 7.2	09:35 - 09:55	Hepatitis B virus: Genotypic and virological resistance
		Pei-Jer Chen, Taipei
CS 7.3	09:55 - 10:15	cccDNA function and HBV replication
		Massimo Levrero, Rome
CS 7.4	10:15 - 10:35	Tools for the assessment of HBV resistance in clinical practice
		Vincent W.S. Wong, Hong Kong
	10:35 - 10:45	Discussion
09:15 - 10:30		Concurrent Session 8
Meeting Room 311A		DICID-GCACMID Joint Symposium I - Facing the Challenge of Novel Bugs
	09:15 - 09:20	Opening Remarks
		Minjun Chen, Beijing
		Po-Ren Hsueh, Taipei
		Jun Cheng, Beijing
		Yuxing Ni, Shanghai
		Wing-Hong Seto, Hoong Kong
CS 8.1	09:20 - 09:40	Antimicrobial therapy: discrepancy between in vitro susceptibility and in vivo efficacy
		Moderator: Cheng-Yi Liu, Taipei
		Jiunn-Jong Wu,Tainan
		Speaker: Baiyi Chen, Shenyang
CS 8.2	09:40 - 10:00	CLSI or EUCAST: which one should we have
		Moderator: Cheng-Yi Liu, Taipei
		Jiunn-Jong Wu,Tainan
		Speaker: Wen-Chien Ko, Tainan
CS 8.3	10:00 - 10:20	Group A streptococcal infection
		Moderator: Cheng-Yi Liu, Taipei
		Jiunn-Jong Wu,Tainan
		Speaker: Yonghong Yang
CS 8.4	10:20 - 10:30	Panel Discussion
09:15 - 10:45		Concurrent Session 9
Meeting Room 311B		Influenza
CS 9.1	09:15 - 09:35	Screening of influenza
		Lance C. Jennings, Christchurch
CS 9.1	09:35 - 09:55	The emergence of pandemic influenza viruses
		Gavin J. D. Smith, Singapore
CS 9.3	09:55 - 10:15	Safety and Effectiveness of a 2009 H1N1 Vaccine in Beijing Screening of influenza
		TBC
CS 9.4	10:15 - 10:35	Antiviral treatment of H1N1: Virological response and resistance
		Paul K. S. Chan, Hong Kong
	10:35 - 10:45	Discussion
10:45 - 11:15		Poster Session / Coffee Break
11:15 - 11:45		State-of-the Art Lecture 4
Meeting Room 309
SOTA 4	11:15 - 11:45	Molecular genesis of drug-resistant HBV
		Stephen A. Locarnini, North Melborne
11:45 - 13:30		Poster Session / Lunch
12:00 - 13:00		ASAP/ASPID Symosium
Meeting Room 310		Pneumonia and Pneumococcal Disease Burden in Asia: Protecting our Children
	12:00 - 12:05	Introduction
		Lulu C. Bravo, Manila
	12:05 - 12:20	Pneumococcal Disease Burden in Pneumonia, Meningitis and Otitis Media
		Cheng-Hsun Chiu, Taoyuan
	12:20 - 12:35	Pneumococcal Disease in China
		Yonghong Yang, Beijing
	12:35 - 12:45	Global Action Plan for Pneumonia Prevention (GAPP)
		Daniel Goh, Singapore
	12:45 - 12:50	Call for Action-Activities Around the World
		Wok-Wan Chan, Hong Kong
	12:50 - 13:00	Open Forum
11:45 - 13:15		Free Paper Presentation 4
Meeting Room 311A		Basic Science & Laboratory Development
11:45 - 13:15		Free Paper Presentation 5
Meeting Room 311B		Tuberculosis
13:30 - 15:00		Concurrent Session 10
Meeting Room 310		Management of CHB - Factors and Trends
CS 10.1	13:50 - 14:10	HBsAg seroconversion as treatment endpoint: Phenomenon and reality
		Jinlin Hou, Guangzhou
CS 10.2	14:10 - 14:30	A beeter clinical practice through quantitative HBsAg levels
		Jun Yong Park, Seoul
CS 10.3	14:30 - 15:00	The cost effectiveness of various strategies for HBV treatment resistance
		Seng-Gee Lim, Singapore
	14:50 - 15:00	Discussion
13:30 - 14:40		Concurrent Session 11
Meeting Room 311A		DICID-GCACMID Joint Symposium II - Facing the Challenge of Novel Bugs
	13:30 - 13:35	Opening Remarks
		Minjun Chen, Beijing
		Po-Ren Hsueh, Taipei
		Jun Cheng, Beijing
		Yuxing Ni, Shanghai
		Wing-Hong Seto, Hong Kong
CS 11.1	13:35 - 13:55	CA-MRSA and hVISA: global and regional aspects
		Moderator: Cheng-Yi Liu, Taipei
		Jiunn-Jong Wu,Tainan
		Speaker: Yunsong Yu, Hangzhou
CS 11.2	13:55 - 14:15	Clostridium difficile infection: an emerging threat
		Moderator: Cheng-Yi Liu, Taipei
		Jiunn-Jong Wu,Tainan
		Speaker: Minggui Wang
CS 11.3	14:15 - 14:35	Control of H1N1 infection
		Moderator: Cheng-Yi Liu, Taipei
		Jiunn-Jong Wu,Tainan
		Speaker: Muh-Yong Yen
	14:35 - 14:40	Panel Discussion
13:30 - 15:00		Concurrent Session 12
Meeting Room 311B		Tuberculosis
CS 12.1	13:30 - 13:50	New tools for achieving tuberculosis control
		Wing-Wai Yew, Hong Kong
CS 12.2	13:50 - 14:10	Recent advencement in diagnosis of TB
		Cynthia B.E. Chee, Singapore
CS 12.3	14:10 - 14:30	A novel rapid assay to screen for rpsL gene mutations
		Wenhong Zhang, Shanghai
CS 12.4	14:30 - 15:00	Extensively drug-resistant tuberculosis (XDR-TB) in China: Clinical characteristics and treatment outcomes
		Qing Zhang, Shanghai
	14:50 - 15:00	Discussion
15:30 - 17:00		General Session 2
Meeting Room 309		Decision Making in CHB Patients Management
GS 2.1	15:30 - 16:00	Indication to start therapy - possible, optional and mandatory
		Massimo Levrero, Rome
GS 2.2	16:00 - 16:30	Treatment endpoints for HBV
		Chun-Jen Liu, Taipei
GS 2.3	16:30 - 17:00	Management of CHB patients: Considerations for the difficult cases and special populations
		Jidong Jia, Beijing
15:30 - 17:00		Free Paper Presentation 6
Meeting Room 310		Hepatitis B
15:30 - 17:00		Free Paper Presentation 7
Meeting Room 311A		Social and Public Health Issues
15:30 - 17:00		Free Paper Presentation 8
Meeting Room 311B		Bacterial Infections